Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Robert Nelson

Orthopaedic Surgery Riverdale, GA Medical Doctor

NPI 1871532937 CMS profile 530666

107 Upper Riverdale Rd Sw, Ste A, Riverdale, GA 30274

Open in the dashboard

General payments

$2,421

26 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Robert Nelson of Riverdale, GA is reported in the CMS Open Payments database as having received $2,421 across 26 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 43rd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $115 1
2022 General $837 9
2021 General $86 3
2020 General $74 3
2019 General $1,309 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Nelson
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Robert Nelson were reported at $0. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Robert Nelson Orthopaedic Surgery median Middle half National median
2019 $1,309 $644 $140–$2,844 $163
2020 $74 $312 $75–$1,860 $114
2021 $86 $520 $117–$2,495 $132
2022 $837 $598 $128–$2,731 $149
2023 $115 $461 $128–$2,264 $160
2024 $0 $497 $134–$2,475 $164
2025 $0 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Exactech, Inc. $1,856 7 payments
  2. Avanos Medical $148 2 payments
  3. Flexion Therapeutics, Inc. $136 3 payments
  4. TELA Bio, Inc. $40 1 payment
  5. Next Science LLC $40 2 payments
  6. Ethicon US, LLC $37 1 payment
  7. Kowa Pharmaceuticals America, Inc. $36 2 payments
  8. Baxter Healthcare $33 2 payments
  9. Integra LifeSciences Corporation $29 2 payments
  10. Zimmer Biomet Holdings, Inc. $20 1 payment
  11. Other $46 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $1,298 22 payments
  2. Travel and Lodging $1,123 4 payments
Products named General payments · program years 2019–2023
  1. NOVATION HIP $1,133 4 payments
  2. Equinoxe $723 3 payments
  3. COOLIEF* COOLED RADIOFREQUENCY $148 2 payments
  4. Zilretta $136 3 payments
  5. OviTex $40 1 payment
  6. SurgX $40 2 payments
  7. Xperience $40 2 payments
  8. BlastX $40 2 payments
  9. ETHICON $37 1 payment
  10. Seglentis $36 2 payments
  11. Other $231 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 20 drugs

Part D claims

2,292

Median for Orthopaedic Surgery: 30

Drug cost

$55,492

Median for Orthopaedic Surgery: $176

Branded share of claims

34%

Median for Orthopaedic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 489 $12,909
Buprenorphine Generic 36 $9,865
Oxycontin Oxycodone Hcl Brand 16 $7,561
Xtampza Er Oxycodone Myristate Brand 15 $5,682
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 218 $5,065
Tizanidine Hcl Generic 368 $3,253
Gabapentin Generic 283 $2,934
Ibuprofen Generic 244 $1,666
Pregabalin Generic 98 $1,411
Diclofenac Sodium Generic 52 $983

The 10 drugs with the highest cost, of 20 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,233 Part D prescribers listed as Orthopaedic Surgery; they describe a distribution and say nothing about conduct.

Records

26 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record